Cart
sales@molnova.com
Reglitazar
CAS No. 170861-63-9
Reglitazar( —— )
Catalog No. M34392 CAS No. 170861-63-9
Reglitazar (JTT-501) is a dual PPARα and PPARγ agonist that is used to study diabetes.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 686 | In Stock |
|
| 10MG | 938 | In Stock |
|
| 25MG | 1444 | In Stock |
|
| 50MG | 1841 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameReglitazar
-
NoteResearch use only, not for human use.
-
Brief DescriptionReglitazar (JTT-501) is a dual PPARα and PPARγ agonist that is used to study diabetes.
-
DescriptionReglitazar (JTT-501) is a dual PPARα and PPARγ agonist that is used to study diabetes.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMetabolic Enzyme/Protease
-
TargetPPAR
-
RecptorPPAR
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number170861-63-9
-
Formula Weight392.4
-
Molecular FormulaC22H20N2O5
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C1ONC(=O)C1CC2=CC=C(OCCC=3N=C(OC3C)C=4C=CC=CC4)C=C2
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Pioglitazone hydroch...
Pioglitazone hydrochloride can increase both insulin-stimulated glucose uptake in peripheral tissues and insulin sensitivity in hepatic and adipose tissue.
-
Ragaglitazar
Ragaglitazar(NNC-61-0029) is a potent dual activator of PPARγ and PPARα, which shows improved insulin sensitization and lipid-lowering potential in animal models and can be used to study type 2 diabetes.
-
MSDC-0602K
MSDC-0602K (Azemiglitazone potassium) (Azemiglitazone potassium) is a PPARγ-sparing thiazolidinedione (Ps-TZD) compound that binds to PPARγ with an IC50 of 18.25 μM.
